Keywords: adr، adriamycin; LC, liver cystatin; ADR, adriamycin; CD, circular dichroism; Ka, binding constant; HBV, human hepatitis B virusLiver cystatin; Adriamycin; Adevofir dipivoxil; Fluorescence; UV-spectroscopy
مقالات ISI adr، adriamycin (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: adr، adriamycin; Lamprey; Prohibitin; Oxidative stress; Translocation; Human chang liver cellsPHB2, prohibitin 2; CHL cell, Chang liver cell; Adr, adriamycin; SOD, superoxide dismutase; Prx2, peroxiredoxin2; LDH, lactate dehydrogenase; XOR, xanthine oxidoreductase
Keywords: adr، adriamycin; ADR, adriamycin; AQCOM, alginate-Q-CMCS-organic montmorillonite; bFGF, basic fibroblast growth gactor; BSA, bovine serum albumin; BMSCs, bone marrow stromal cells; CPT, camptothecin; CMC, critical micelle concentration; CMCS, carboxymethyl chitosan; O-CMC
Keywords: adr، adriamycin; ADR, adriamycin; AMD, age-related macular degeneration; ATP, adenosine triphosphate; CNV, choroidal neovascularisation; DIO, diosmetin; H&E, hematoxylin and eosin; IC50, inhibition for 50% of the cells; IVI, intravitreal injection; PVR, proliferative vitr
miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression
Keywords: adr، adriamycin; Adr, Adriamycin; microRNA, miRNA; Bak1, Bcl-2 Antagonist Killer 1; 3ʹUTR, 3′-untranslation region; SOCS1, suppressor of cytokine signaling 1; CDKN1B, cyclin-dependent kinase inhibit 1BmiR-222; Adriamycin; Drug resistance; p27kip1; Breast cancer
MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway
Keywords: adr، adriamycin; ADR, adriamycin; miRNAs, microRNAs; IGF-1R, insulin-like growth factor-1 receptor; GSK3β, Glycogen Synthase Kinase 3β; PTEN, phosphatase and tensin homolog deleted on chromosome 10; PI3K, phosphatidylinositol 3-kinase; IC50, the inhibitory concentration t
Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway
Keywords: adr، adriamycin; Soluble epoxide hydrolase; Proteinuria; Epithelial-mesenchymal transition; Adriamycin-induced nephropathyα-SMA, alpha-smooth muscle actin; ADR, Adriamycin; AUDA, 12- (3-adamantan-1-yl-ureido)- dodecanoic acid; EETs, epoxyeicosatrienoic acids; EMT, epithel
Synthesis, characterization, structures and cytotoxicity of platinum(II) complexes containing dimethylpyrazole based selenium ligands
Keywords: adr، adriamycin; en, ethylenediamine; dmpz, 3,5-dimethylpyrazole; ROS, reactive oxygen species; ADR, adriamycin; LC50, concentration of test complex that kills 50% of the cells; TGI, concentration of test complex that produces 100% inhibition of cells; GI50, concentration
Design and synthesis of 2-phenylnaphthalenoids and 2-phenylbenzofuranoids as DNA topoisomerase inhibitors and antitumor agents
Keywords: adr، adriamycin; 2-Phenylnaphthalenoids; 2-Phenylbenzofuranoids; Topoisomerase IIα inhibitor; Antitumor2PBFs, 2-Phenylbenzofuranoids; 2PNs, 2-Phenylnaphthalenoids; 3D-QSAR, Three-dimensional quantitative structure–activity relationships; ADR, Adriamycin; ATCC, American Ty
Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo
Keywords: adr، adriamycin; ABC, ATP-binding cassette; Caco-2 cells, human colon adenocarcinoma cells; MDR, multidrug resistance; MDR1, multidrug resistance 1; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTX, methotrexate; ADR, adriamycin; Ver, verapamil; Rif,
miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells
Keywords: adr، adriamycin; Adr, adriamycin; Doc, docetaxel; miRNA, microRNA; miR, microRNA; mRNA, messenger RNA; IC50, inhibitory concentration to produce 50% cell death; DMEM, Dulbecco's modified Eagle's medium; RT-qPCR, real-time quantitative PCR; PTEN, phosphatase and tensin hom
Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells
Keywords: adr، adriamycin; ADR, adriamycin; AML, acute myeloid leukemia; DNR, daunorubicin; ECL, enhanced chemiluminescence; IC50, half inhibitory concentration; LV, lentivirus; MDR, multidrug resistance; NPM, nucleophosmin; NBT, nitroblue tetrazolium reduction; PI, propidium iodid
Genome-wide cDNA microarray screening to reveal gene-expression profiles correlated to chemosensitivity of oral squamous cell carcinoma cell lines
Keywords: adr، adriamycin; OSCC, oral squamous cell carcinoma; CD-DST, collagen gel droplet embedded culture-drug sensitivity test; 5Fu, 5-fluorouracil; CDDP, cisplatin; TXT, docetaxel; MMC, mitomycin C; ADR, adriamycin; T/C (%), relative tumor volume with respect to controlsOral c
Post-translational modifications of superoxide dismutase
Keywords: adr، adriamycin; ADR, adriamycin; I/R, Ischemia/reperfusion; iNOS, inducible nitric oxide synthase; eNOS, endotherial nitric oxide synthase; nNOS, neuronal nitric oxide synthase; PAGE, polyacrylamide gel electrophoresis; RNS, reactive nitrogen species; SOD, superoxide dis
Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis
Keywords: adr، adriamycin; HIPK2, homeodomain-interacting protein kinase-2; ADR, adriamycin; Dox, doxycycline; Nic, nicotinamide; Nox, NADPH oxidase; HEK-293, human embryo kidney; PARP, poly(ADP-ribose) polymerase; ROS, reactive oxygen species; RT-PCR, reverse transcriptase–polymer
Gambogic acid triggers DNA damage signaling that induces p53/p21Waf1/CIP1 activation through the ATR-Chk1 pathway
Keywords: adr، adriamycin; ATM, ataxia telangiectasia mutated; ATR, ataxia telangiectasia and Rad3-related; Adr, adriamycin; Caff, caffeine; DMSO, dimethyl sulfoxide; Dox, doxycycline; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; GA, gambogic acid; kd, kinase dead; PI
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: Current status
Keywords: adr، adriamycin; 1D, one-dimensional; 1D-PAGE, one-dimensional polyacrylamide gel electrophoresis; 2D-DIGE, two-dimensional difference gel electrophoresis; 2D, two dimensional; 2D-PAGE, two dimensional polyacrylamide gel electrophoresis; Adr, adriamycin; AQUA, absolute qu
Primary diffuse leptomeningeal gliomatosis in a 2-year-old girl
Keywords: adr، adriamycin; ACNU, nimustine; ADR, adriamycin; AFP, α-feto protein; AMP, allarubilin/6-mercaptopurine/prednisolone; ARA, cytosine-arabinoside; CA, cytarabine; CCT, cranial computer tomography; CCNU, lomustine; cMRI, cranial magnetic resonance imaging; CNS, central ner
Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats
Keywords: adr، adriamycin; ADR, adriamycin; GSH, reduced glutathione; i.p., intraperitoneally; LDH, lactate dehydrogenase; CPK, creatine phosphokinase; MDA, malondialdehydeAdriamycin; Silymarin; Cardiotoxicity; Nephrotoxicity; Lipid peroxidation; GSH
Surgical implications for liver metastases in nephroblastoma—Data from the SIOP/GPOH study
Keywords: adr، adriamycin; ACT-D, dactinomycin; ADR, adriamycin; AVD, ACT-D, VCR, DOX; CARBO, carboplatin; CCE, CARBO, CYCLO, VP 16, G-CSF; CCED, CARBO, CYCLO, VP 16, DOX; CCEV, CARBO, CYCLO, VP 16, VCR; CR, complete remission; CRF, case report form; CT, computer tomography; CYCLO,
Amelioration of anti-cancer agent adriamycin-induced nephrotic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine
Keywords: adr، adriamycin; ADR, adriamycin; WLS, Wulingsan; ALP, alkaline phosphatase; BUN, blood urea nitrogen; ALT, alanine aminotransferase; AST, aspartate aminotransferase; tBil, total bilirubin; RIA, radioimmunoassayWulingsan; Nephrotic syndrome; Podocyte; Nephrin; Adriamycin;
Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis
Keywords: adr، adriamycin; ADR, adriamycin; DCF, 2’,7’-dichlorofluorescein; DHE, dihydroethidium; DMEM, Dulbecco’s modified Eagle’s medium; DMSO, dimethyl sulfoxide; H2DCF-DA, 2’,7’-dichlorofluorescein diacetate; MTT, 3-(4,5-dimethyl thiazol-2yl)-2,5-diphenyltetrazolium bromide; NI
Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury
Keywords: adr، adriamycin; ADR, adriamycin; HAT, histone acetyltransferase; HDAC, histone deacetylase; HDACI, HDAC inhibitor; PBA, phenylbutyric acid; LDH, lactate dehydrogenase; CK, creatine kinase; MnSOD, manganese superoxide dismutase; DETAPAC, diethylenetriaminepentaacetic acid
PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax
Keywords: adr، adriamycin; PRIMA-1; p53; Apoptosis; Breast cancer; Chromatin immunoprecipitation; ChIP; Bax; PUMA; c-Jun N-terminal kinasePRIMA-1, p53 reactivation and induction of massive apoptosis; p53BS, p53 binding site; ADR, adriamycin; ChIP, chromatin immunoprecipitation; JNK
Redox proteomic identification of oxidized cardiac proteins in Adriamycin-treated mice
Keywords: adr، adriamycin; ADR, adriamycin; TPI, triose phosphate isomerase; ETF-QO, electron transfer flavoprotein–ubiquinone oxidoreductase; IEF, isoelectric focusing; DTT, dithiothreitol; 2-DE, two-dimensional electrophoresis; DNPH, 2,4-dinitrophenylhydrazineAdriamycin; β-Enolas